Dr. Chuang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5800 Hollis St
Emeryville, CA 94608Phone+1 650-498-6000
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1992 - 1995
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1989 - 1992
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1989
Certifications & Licensure
HI State Medical License 2014 - 2026
CA State Medical License 2019 - 2025
MT State Medical License 2024 - 2025
NC State Medical License 2023 - 2025
WA State Medical License 2021 - 2024
NY State Medical License 1999 - 2015
IL State Medical License 1996 - 2002- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer Start of enrollment: 2006 Jan 01
- A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1 Start of enrollment: 2009 Sep 01
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsCorrection: Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recur...Nancy Chan, Amy Willis, Naomi Kornhauser, Maureen M Ward, Sharrell B Lee
Clinical Cancer Research. 2020-09-15 - 54 citationsInfluencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in...Nancy Chan, Amy Willis, Naomi Kornhauser, Maureen M Ward, Sharrell B Lee
Clinical Cancer Research. 2017-02-01 - 45 citationsClinical and Translational Results of a Phase II, Randomized Trial of an Anti–IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine TherapyWilliam J. Gradishar, Denise A. Yardley, Rachel M. Layman, Joseph A. Sparano, Ellen Chuang
Clinical Cancer Research. 2016-01-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
